LA JOLLA PHARMACEUTICAL CO
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: LA JOLLA PHARMACEUTICAL CO, 10-Q, EX-10.19, 2000-11-14
Next: ALTERNATIVE RESOURCES CORP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER>1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           7,128
<SECURITIES>                                    35,378
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 1,064
<PP&E>                                           4,602
<DEPRECIATION>                                  (3,969)
<TOTAL-ASSETS>                                  45,874
<CURRENT-LIABILITIES>                            2,648
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           293
<OTHER-SE>                                      42,933
<TOTAL-LIABILITY-AND-EQUITY>                    45,874
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                11,249
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   6
<INCOME-PRETAX>                                (10,094)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (10,094)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (10,094)
<EPS-BASIC>                                    (0.41)
<EPS-DILUTED>                                    (0.41)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission